K-Y Jelly buyout could push up prices of lubricant, competition watchdog warns Prices for sexual lubricants could go up if a planned buyout of
Geron's Rytelo for MDS cleared by FDA without a warning label, boosting its value and buyout prospects. The web page also covers other biotech news, such as Califf's comments on China and GLP-1s, Shionogi's obesity drug failure and AbbVie's ovarian cancer data.
Geron is currently in prime buy-out territory to get it cheap, or we could still be waiting another 4 years, with more dilution. My current, completely biased view, towards a buyout being soon, is based on the fact Gern has yet to start hiring a sales force or announce a European partner.
geron- tology. He is a licensed nursing home administrator, a BUYOUT OPTION.There are au- thorized to be appropriated to the
The rumors are rumors. There is a bacillus that was discovered in the permafrost on Mammoth Mountain in Russia. It is about 3 million years old.
Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that it has granted non-statutory stock options to purchase an aggregate of 222,660 shares of Geron Business Wire 3mo ago
On average, Wall Street analysts predict that Geron's share price could reach $7.21 by . The average Geron stock price prediction forecasts a
That could boost buyout interest in Geron, as well as in Rytelo's launch, Stifel analyst Stephen Willey wrote in a research note. Shares
K-Y Jelly buyout could push up prices of lubricant, competition watchdog warns Prices for sexual lubricants could go up if a planned buyout of
Comments
The Showalters had recently divorced amidst rumors of divorce on the part of Mrs. Showalter.
rumors of infidelity not divorce